Patents by Inventor Cornelia Dorner-Clossek

Cornelia Dorner-Clossek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating diseases and conditions associated with an altered level of amyloid ? peptides and new enolcarboxamide compounds
    Patent number: 7393843
    Abstract: A method of treating or preventing of a disease or condition associated with an increased level of isoforms of amyloid ? peptides (A?) and/or with a changed ratio of levels of A? isoforms and/or with the formation of plaques containing amyloid ? peptide (A?) isoforms in a mammal comprising administering to said mammal an therapeutically effective amount of a compound selected from the formulas Ia, Ib wherein V, W, Y, R2, R3, R5, R6, L1 and i are defined as in claim 1.
    Type: Grant
    Filed: May 19, 2005
    Date of Patent: July 1, 2008
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Klaus Bornemann, Guenter Trummlitz, Bernd Beck, Frank Sams-Dodd, Dagmar Kugler, Klaus Klinder, Cornelia Dorner-Clossek, Marcus Kostka
  • Trisubstituted pyrimidines
    Publication number: 20030134838
    Abstract: The present invention relates to trisubstituted pyrimidines of formula 1
    Type: Application
    Filed: October 16, 2002
    Publication date: July 17, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Klaus Bornemann, Hans Briem, Cornelia Dorner-Clossek, Katja Fechteler, Klaus Fuchs, Frank Himmelsbach, Klaus Klinder, Markus Kostka